Incretins and Type-2 Diabetes: Discovering a New Piece of the Puzzle

 
Merck December, 2006
 

This multi-award winning 3D animation depicts the mechanism of action of Januvia, a new Type-2 diabetes drug. Due to the multitude of treatment therapies and because the mechanism of action of this molecule is quite complex, a visual story greatly enhanced physicians' understanding as to why, compared to current treatments, it may be so effective in lowering blood sugar levels.

Agency Partner: None
Awards: 3 Tellys, 1 Rx Club, Global Award Finalist